• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Influence of polymorphic form, morphology, and excipient interactions on the dissolution of carbamazepine compacts.

作者信息

Tian Fang, Sandler Niklas, Aaltonen Jaakko, Lang Carolin, Saville Dorothy J, Gordon Keith C, Strachan Clare J, Rantanen Jukka, Rades Thomas

机构信息

School of Pharmacy, University of Otago, P.O. Box 913, Dunedin, New Zealand.

出版信息

J Pharm Sci. 2007 Mar;96(3):584-94. doi: 10.1002/jps.20756.

DOI:10.1002/jps.20756
PMID:17080412
Abstract

To gain a deeper understanding of the behavior of carbamazepine (CBZ) and CBZ dihydrate (DH) compacts during in vitro dissolution tests various factors were investigated: hydrate formation of CBZ, crystal morphology, surface area, and excipient influence. Dissolution tests were performed in three different dissolution media: distilled water, hydroxypropyl methylcellulose (HPMC), and polyethylene glycol (PEG) solutions. For the CBZ compacts, the dissolution rate of CBZ in water was fastest (0.338 mg L(-1) min(-1)). With increasing ability of the excipients to inhibit the hydration of CBZ (PEG < HPMC), surprisingly the dissolution rate of CBZ compacts decreased: PEG solution (0.314 mg L(-1) min(-1)) > HPMC solution (0.257 mg L(-1) min(-1)). This implies that DH formation resulted in an apparent increase in the dissolution rate rather than slowing it down. For the DH compacts, the dissolution rate in water (0.055 mg L(-1) min(-1)) was slower than that of PEG and HPMC solutions (0.174 and 0.178 mg L(-1) min(-1), respectively). The contact angle measurements showed a significantly higher value in water (61.0 degrees) than in PEG and HPMC solutions (44.8 degrees and 43.1 degrees, respectively). Although the dissolution of CBZ and DH compacts in various dissolution media are complex processes, the influence and relative importance of these factors were clearly detected providing better understanding of the dissolution behavior of the drug.

摘要

相似文献

1
Influence of polymorphic form, morphology, and excipient interactions on the dissolution of carbamazepine compacts.
J Pharm Sci. 2007 Mar;96(3):584-94. doi: 10.1002/jps.20756.
2
Visualizing the conversion of carbamazepine in aqueous suspension with and without the presence of excipients: a single crystal study using SEM and Raman microscopy.可视化卡马西平在有无辅料存在的水悬浮液中的转化:使用扫描电子显微镜和拉曼显微镜的单晶研究
Eur J Pharm Biopharm. 2006 Nov;64(3):326-35. doi: 10.1016/j.ejpb.2006.05.014. Epub 2006 Jun 3.
3
Effects of coformers on phase transformation and release profiles of carbamazepine cocrystals in hydroxypropyl methylcellulose based matrix tablets.共晶剂对依托泊苷共晶在羟丙甲纤维素基质片中的相转变和释放行为的影响。
Int J Pharm. 2015 Feb 1;479(1):118-28. doi: 10.1016/j.ijpharm.2014.12.049. Epub 2014 Dec 24.
4
In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.新型速释卡马西平片的体外和体内评价:在 HPMC 存在下与羟丙基-β-环糊精的络合作用。
Int J Pharm. 2011 May 16;409(1-2):75-80. doi: 10.1016/j.ijpharm.2011.02.042. Epub 2011 Mar 1.
5
In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.原位监测卡马西平-烟酰胺共晶的内在溶解行为。
Eur J Pharm Biopharm. 2013 Apr;83(3):415-26. doi: 10.1016/j.ejpb.2012.10.005. Epub 2012 Nov 16.
6
Carbamazepine/betaCD/HPMC solid dispersions. I. Influence of the spray-drying process and betaCD/HPMC on the drug dissolution profile.卡马西平/β-环糊精/羟丙基甲基纤维素固体分散体。I.喷雾干燥工艺及β-环糊精/羟丙基甲基纤维素对药物溶出曲线的影响。
Drug Dev Ind Pharm. 2003 Feb;29(2):139-44. doi: 10.1081/ddc-120016721.
7
Investigation of intrinsic dissolution behavior of different carbamazepine samples.不同卡马西平样品的内在溶解行为研究。
Int J Pharm. 2010 Feb 15;386(1-2):77-90. doi: 10.1016/j.ijpharm.2009.10.051. Epub 2009 Nov 10.
8
Investigation of the effect of hydroxypropyl methylcellulose on the phase transformation and release profiles of carbamazepine-nicotinamide cocrystal.羟丙基甲基纤维素对卡马西平-烟酰胺共晶体的相变和释放曲线影响的研究。
Pharm Res. 2014 Sep;31(9):2312-25. doi: 10.1007/s11095-014-1326-2. Epub 2014 Mar 4.
9
Mechanistic differences in permeation behavior of supersaturated and solubilized solutions of carbamazepine revealed by nuclear magnetic resonance measurements.通过核磁共振测量揭示卡马西平过饱和及增溶溶液渗透行为的机制差异。
Mol Pharm. 2012 Nov 5;9(11):3023-33. doi: 10.1021/mp300083e. Epub 2012 Sep 28.
10
Dissolution Profiles of Carbamazepine Cocrystals with Cis-Trans Isomeric Coformers.卡马西平共晶与顺反异构体共晶物的溶解曲线。
Pharm Res. 2023 Feb;40(2):579-591. doi: 10.1007/s11095-022-03209-x. Epub 2022 Feb 22.

引用本文的文献

1
Disentangling autoencoders and spherical harmonics for efficient shape classification in crystal growth simulations.在晶体生长模拟中解开自动编码器与球谐函数以实现高效形状分类
Commun Phys. 2025;8(1):272. doi: 10.1038/s42005-025-02129-7. Epub 2025 Jul 2.
2
Polymorphic Solid Solutions in Molecular Crystals: Tips, Tricks, and Switches.分子晶体中的多晶型固溶体:技巧、窍门与转换
J Am Chem Soc. 2023 Sep 20;145(37):20562-20577. doi: 10.1021/jacs.3c07105. Epub 2023 Sep 6.
3
Amorphous Nanoparticulate Formulation of Sirolimus and Its Tablets.
西罗莫司无定形纳米颗粒制剂及其片剂
Pharmaceutics. 2018 Sep 11;10(3):155. doi: 10.3390/pharmaceutics10030155.
4
Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug.润湿动力学:一种理解难溶性药物无定形固体分散体溶出速率提高的替代方法。
AAPS PharmSciTech. 2015 Oct;16(5):1079-90. doi: 10.1208/s12249-014-0281-x. Epub 2015 Feb 12.
5
Carbon dioxide-mediated generation of hybrid nanoparticles for improved bioavailability of protein kinase inhibitors.二氧化碳介导生成杂化纳米颗粒以提高蛋白激酶抑制剂的生物利用度。
Pharm Res. 2014 Mar;31(3):694-705. doi: 10.1007/s11095-013-1191-4. Epub 2013 Aug 30.
6
Visualizing solvent mediated phase transformation behavior of carbamazepine polymorphs by principal component analysis.通过主成分分析可视化卡马西平多晶型物的溶剂介导相变行为
AAPS PharmSciTech. 2008;9(2):390-4. doi: 10.1208/s12249-008-9049-5. Epub 2008 Feb 21.